US Patent 11542278 Heteroaromatic macrocyclic ether chemotherapeutic agents
Patent 11542278 was granted and assigned to Nuvalent on January, 2023 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
October 29, 2021
Date of Patent
January 3, 2023
Patent Applicant
Patent Application Number
17514877
Patent Citations
Patent Jurisdiction
Patent Number
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11542278 Heteroaromatic macrocyclic ether chemotherapeutic agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
